Promoted Content Promoted Content

X

Find Novel Drugs for Trauma (Emergency, Injury, Surgery) under Development in UNITED STATES

Loading...

All Data

Filters Filter refresh
×
FILTER DATA :
News Type filter
    Company filter
      Product Type filter
        Deal Size filter
          Upfront Payment filter
            refresh

            Product Type Full Screen

            Companies Full Screen

            Virtual Booth Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

            Contact the Supplier

            Lead Product(s): Rusalatide Acetate

            Therapeutic Area: Trauma (Emergency, Injury, Surgery) Product Name: TP508

            Highest Development Status: Undisclosed Product Type: Peptide

            Partner/Sponsor/Collaborator: BARDA

            Deal Size: $10.4 million Upfront Cash: Undisclosed

            Deal Type: Funding December 01, 2020

            Details:

            Chrysalis will conduct safety studies and additional options required to achieve Emergency Use Authorization and Animal Rule approval for TP508 as a medicinal treatment for acute and delayed effects of ionizing radiation exposure.

            Virtual Booth Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

            Contact the Supplier

            Lead Product(s): Blood cell therapy

            Therapeutic Area: Trauma (Emergency, Injury, Surgery) Product Name: Undisclosed

            Highest Development Status: Undisclosed Product Type: Cell and Gene therapy

            Partner/Sponsor/Collaborator: iBio

            Deal Size: $1.5 million Upfront Cash: Undisclosed

            Deal Type: Agreement October 02, 2020

            Details:

            iBio will manufacture 10 proteins to be tested in the production of Safi’s cell therapies as part of the first Statement of Work. Safi will have the option to designate certain proteins as proprietary to their bioprocess, but iBio will have rights to market all other products.